409 related articles for article (PubMed ID: 17249210)
1. Study of the significance of percentage of peripheral CD4+ & CD8+ T cells and the hepatitis C virus genotypes in Egyptian patients with chronic hepatitis C.
Madwar M; Talkhan H; el-Salam A; Gabal HA; Zikery A; Gharieb H
J Egypt Public Health Assoc; 1998; 73(1-2):41-55. PubMed ID: 17249210
[TBL] [Abstract][Full Text] [Related]
2. Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection.
Sreenarasimhaiah J; Jaramillo A; Crippin J; Lisker-Melman M; Chapman WC; Mohanakumar T
Hum Immunol; 2003 May; 64(5):497-504. PubMed ID: 12691700
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
Cramp ME; Rossol S; Chokshi S; Carucci P; Williams R; Naoumov NV
Gastroenterology; 2000 Feb; 118(2):346-55. PubMed ID: 10648463
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.
Zeng QL; Yang B; Sun HQ; Feng GH; Jin L; Zou ZS; Zhang Z; Zhang JY; Wang FS
Mol Cells; 2014 Jan; 37(1):66-73. PubMed ID: 24552712
[TBL] [Abstract][Full Text] [Related]
6. [Effect of antiviral treatment on expression of programmed death 1 and programmed death ligand 1 on peripheral T lymphocytes in patients with chronic hepatitis C].
Cai RT; Shen L; Zhao W; Yang YF; Zhang YC
Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):261-6. PubMed ID: 24021786
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.
Kumthip K; Chusri P; Pantip C; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
J Med Virol; 2014 Aug; 86(8):1360-5. PubMed ID: 24777626
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha.
Voltchek I; Sologub T; Nowicky JW; Grigoryeva T; Belozyorova L; Belopolskaya M; Semenyako N; Lamanova E
Drugs Exp Clin Res; 2000; 26(5-6):261-6. PubMed ID: 11345036
[TBL] [Abstract][Full Text] [Related]
9. Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt.
Elrefaei M; El-sheikh N; Kamal K; Cao H
J Hepatol; 2004 Feb; 40(2):313-8. PubMed ID: 14739104
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C.
Karino Y; Toyota J; Sugawara M; Miyazaki K; Kuwata Y; Yamazaki K; Sato T; Ohmura T; Matsushima T
J Gastroenterol Hepatol; 2003 Apr; 18(4):404-10. PubMed ID: 12653888
[TBL] [Abstract][Full Text] [Related]
11. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
[TBL] [Abstract][Full Text] [Related]
12. A multicentric and nationwide predictive study role of T cell sub-population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients.
Abdel-Samiee M; Youssef MI; Elghamry F; Bazeed M; Al-Shorbagy M; Shalaby H; Shabana H; Abdelsameea E; Lashin HES; El Zamek HMF; Esam T; Alwaseef MAA; Helmy HA; Almarshad F; Khalaf FA; Yossef BWA; Kassem A; Gabr BM; Abdelfattah A; S AboShabaan H; Aboufarrag GA; Omar MM; Bakeer MS; Imam MS; Ibrahim ES; Kamel SY; Allisy T; Mohammed OS; Farahat A; El-Khayat MM; Sekeen MAH; Zaher EM; Said A; Abuamer A; Elmahdi E
J Med Virol; 2023 Dec; 95(12):e29248. PubMed ID: 38108641
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
Myers RP; Benhamou Y; Bochet M; Thibault V; Mehri D; Poynard T
AIDS; 2004 Jan; 18(1):75-9. PubMed ID: 15090832
[TBL] [Abstract][Full Text] [Related]
14. Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta.
Chalupa P; Davidová A; Beran O; Arientová S; Boštík P; Kapla J; Kondělková K; Plíšek S; Holub M
APMIS; 2016 Aug; 124(8):711-8. PubMed ID: 27307383
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection.
Pham TN; King D; Macparland SA; McGrath JS; Reddy SB; Bursey FR; Michalak TI
Gastroenterology; 2008 Mar; 134(3):812-22. PubMed ID: 18243182
[TBL] [Abstract][Full Text] [Related]
16. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME
HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132
[TBL] [Abstract][Full Text] [Related]
17. Immunological and virological predictors of outcome during interferon-alpha therapy of chronic hepatitis C.
Saito H; Ebinuma H; Satoh I; Miyaguchi S; Tada S; Iwabuchi N; Kumagai N; Tsuchimoto K; Morizane T; Ishii H
J Viral Hepat; 2000 Jan; 7(1):64-74. PubMed ID: 10718945
[TBL] [Abstract][Full Text] [Related]
18. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4.
Zekri AR; El-Din HM; Bahnassy AA; Khaled MM; Omar A; Fouad I; El-Hefnewi M; Thakeb F; El-Awady M
Virol J; 2007 Feb; 4():16. PubMed ID: 17300723
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of the association between paraoxonase-1 gene polymorphisms and response to therapy in chronic hepatitis C patients].
Kıratlı K; Gül HC; Artuk C; Kozan S; Oztuna A; Tunca Y; Eyigün CP
Mikrobiyol Bul; 2014 Oct; 48(4):596-605. PubMed ID: 25492655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
